Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics
08/12/2025 13:58
Dec 8 (Reuters) - HBM HEALTHCARE INVESTMENTS AG HBMN.S: MIRUM PHARMACEUTICALS TO ACQUIRE HBM PORTFOLIO COMPANY BLUEJAY THERAPEUTICS FOR UP TO USD 820 MLN MIRUM TO PAY USD 250 MLN CASH AND USD 370 MLN IN STOCK POTENTIAL MILESTONE PAYMENTS UP TO USD 200 MLN IN CASH HBM TO RECEIVE USD 6 MLN CASH AND USD 7 MLN IN SHARES ADDITIONAL PAYMENTS UP TO USD 3.7 MLN UPON MILESTONES Source text: ID:nEQ4XxTjfa Further company coverage: HBMN.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on HBM Healthcare Investments AG
See all newsBrief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics
Media: DKSH said to bid for Swiss drug distributor Swixx Biopharma - Bloomberg News